This initiative aims at reinforcing our commitment to connecting foreign and Brazilian companies, in addition to expanding their contact with potential business partners in Latin America.
HYBRID EDITION
MAY 20ST – Face-to-face meetings at São Paulo
MAY 21ND to 23TH – Online meetings
Participating companies can attend the face-to-face event and continue their contacts in digital format or choose just one form of participation.
All the information concentrated in a single space – your meeting agenda that you access directly in our system.
ONLINE EDITION
SEPTEMBER 23th TO 26TH – Online meetings
Extended meeting times: during the digital meetings you will have a wider choice of meeting times. This allows participants to adapt their meetings to different time zones, thus increasing the possibility of contacts with foreign participants during the event.
In four clicks you can make contact with potential business partners.
SECURE YOUR PARTICIPATION NOW
REGISTER NOWCHECK OUR NUMBERS
A fertile environment focused on generating business with the pharmaceutical industry
2008
16 YEARS SINCE IT WAS FOUNDED IN BRAZIL
300
ABOUT 300 COMPANIES FROM 25 COUNTRIES PARTICIPATED IN PHARMA MEETING BRAZIL
5.220
5.220 MEETINGS SINCE 2008
WHO SHOULD PARTICIPATE?
Companies in the pharmaceutical and healthcare industry that are offering or looking for licensing opportunities (in and out), co-marketing, co-promotion, as well as companies specialized in drug research and development, production outsourcing, development of new applications, and APIs supply.
CONFIRMED PARTICIPANTS
A BRAND
It is offered by the Clube de Novos Negócios. Created in 2003, CLNN aims to promote networking between pharmaceutical professionals who work in business development and licensing. Since its creation, CLNN has acted as a catalyst for opportunities between companies that aim to access the Brazilian pharmaceutical markets through alliances and partnerships. To increase the contact B2B, in 2008 Pharma Meeting Brazil ® has been created. This event is fully dedicated to one-on-one business meetings, between pharmaceutical and healthcare companies, by introducing them to potential global business partners.
